1. HBW Insight
  2. >>Wellness
  3. >>Business
  4. >>Deals

Bausch + Lomb Micronizes Lutein, Zeaxanthin In PreserVision OCUSorb

Analysts: No Small Impact On B+L Credit Rating From Bausch Health Continued Ownership

 
• By Malcolm Spicer

PreserVision AREDS 2 mini-softgel has proprietary OCUSorb formulation with micronized ingredients in a medium-chain triglyceride oil. More than line extensions, though, are needed for B+L to shed influence from Bausch Health’s credit rating.

• Source: Shutterstock

Bausch + Lomb Corp. isn’t resting on the laurels of its consumer health eye care products to drive sales after its spinout from its parent firm in 2022. It’s extending the PreserVision AREDS 2 lutein and zeaxanthin supplement line with a mini-softgel using its proprietary OCUSorb formulation made with micronized forms of the ingredients.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Deals

Italy’s PharmaNutra Grows Presence In Americas And MENA

 
• By Tom Gallen

Iron supplements specialist PharmaNutra has penned distribution deals to take its products to additional markets across the Americas and the Middle East & North Africa.

Azelis Grows Nutraceuticals Offering In Iberia With Solchem

 
• By Tom Gallen

Azelis adds dietary supplement ingredients and a large customer base across Spain to its portfolio with the acquisition of Solchem Nature.

Australia’s Wellnex Life Poised To Enter UK’s CHC Market

 
• By Tom Gallen

Wellnex bringing brands such as Pain Away, Wakey Wakey and Nighty Night to UK market shortly after gaining admission to the the AIM market of the London Stock Exchange.

KKR Expands Health & Beauty Portfolio With Deal For Sweden’s Karo

 
• By Tom Gallen

Consumer health player Karo is changing hands from EQT to KKR in a deal thought to value the Stockholm-based firm at over €2.5bn.

More from Business

Italy’s PharmaNutra Grows Presence In Americas And MENA

 
• By Tom Gallen

Iron supplements specialist PharmaNutra has penned distribution deals to take its products to additional markets across the Americas and the Middle East & North Africa.

French Agency Proposes Effective EU Ban On CBD In Foods And Cosmetics

 
• By David Ridley

France's food safety regulator ANSES is proposing a reproductive toxicity category 1B classification for CBD under the EU's CLP regulation, which would mean an effective ban on CBD in cosmetics and foods. However, French hemp industry association UIVEC hopes that new evidence coming out of a European Commission review will put the issue to bed before it gets that far.

Azelis Grows Nutraceuticals Offering In Iberia With Solchem

 
• By Tom Gallen

Azelis adds dietary supplement ingredients and a large customer base across Spain to its portfolio with the acquisition of Solchem Nature.